Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor.
about
Predicted structures of agonist and antagonist bound complexes of adenosine A3 receptorSynthesis and Binding Affinity of Homologated Adenosine Analogues as A3 Adenosine Receptor Ligands.Medicinal chemistry of the A3 adenosine receptor: agonists, antagonists, and receptor engineering.Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A ReceptorNeoceptors: reengineering GPCRs to recognize tailored ligandsStructure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonistsSelective A(3) adenosine receptor antagonists derived from nucleosides containing a bicyclo[3.1.0]hexane ring system.Design, synthesis, and binding of homologated truncated 4'-thioadenosine derivatives at the human A3 adenosine receptorsThe A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches.Structural Probing and Molecular Modeling of the A₃ Adenosine Receptor: A Focus on Agonist Binding.Predicted structures and dynamics for agonists and antagonists bound to serotonin 5-HT2B and 5-HT2C receptors.Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug Design.Steered molecular dynamics simulation of the binding of the bovine auxilin J domain to the Hsc70 nucleotide-binding domain.Topological sub-structural molecular design (TOPS-MODE): a useful tool to explore key fragments of human A3 adenosine receptor ligands.N6-Substituted 5'-N-Methylcarbamoyl-4'-selenoadenosines as Potent and Selective A3 Adenosine Receptor Agonists with Unusual Sugar Puckering and Nucleobase Orientation.
P2860
Q34975607-1CD85051-5940-4EB6-9590-6D9ED8C56FD4Q35774202-566CB6F6-E77A-4B7C-82AF-D8594B6B3665Q36146803-9B8AC4E4-B473-425E-A6B7-1B7D5BB00FE0Q36482631-55BE55FB-0F5E-44BB-B0EE-10FAA9F91DE3Q36728991-F94A6016-8768-4969-B3A7-5C8CA8548104Q36740173-97B7D4A6-FEFF-4B18-ABDA-9B3A22744195Q36996182-0112758D-7512-4BCF-A018-868691C129F2Q37048000-8F55F40E-1FF0-47EE-8A33-84687AF26017Q37957791-66E02C1F-6215-416B-9F09-38F6B959713AQ38911603-265AC44D-D2AA-4A23-BD9A-56617A4B0F30Q42025199-DB592906-1611-4F27-8F31-B9B829E3E371Q47348749-1FBB5CEE-2D42-4B68-A9F7-BEF474C14DA6Q47612284-6359BB30-C4F4-49DE-B53C-FD97AE344442Q48154944-230901D4-65F9-4200-83CD-92E25F113AE8Q48316436-0B8DCB06-A62C-4857-BC42-847DA6ED3EC2
P2860
Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Docking studies of agonists an ...... of the A3 adenosine receptor.
@ast
Docking studies of agonists an ...... of the A3 adenosine receptor.
@en
Docking studies of agonists an ...... of the A3 adenosine receptor.
@nl
type
label
Docking studies of agonists an ...... of the A3 adenosine receptor.
@ast
Docking studies of agonists an ...... of the A3 adenosine receptor.
@en
Docking studies of agonists an ...... of the A3 adenosine receptor.
@nl
prefLabel
Docking studies of agonists an ...... of the A3 adenosine receptor.
@ast
Docking studies of agonists an ...... of the A3 adenosine receptor.
@en
Docking studies of agonists an ...... of the A3 adenosine receptor.
@nl
P2093
P1476
Docking studies of agonists an ...... of the A3 adenosine receptor.
@en
P2093
Kenneth A Jacobson
Lak Shin Jeong
Soo-Kyung Kim
Zhan-Guo Gao
P304
P356
10.1016/J.JMGM.2006.05.004
P577
2006-05-09T00:00:00Z